Singapore-based Biosyngen receives 500 million yuan in investment
PR Newswire Asia
The investment will allow the biotech form to shorten the time to mass production for their tumor cell therapy pipelines and to..
The investment will allow the biotech form to shorten the time to mass production for their tumor cell therapy pipelines and to..